Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
RAPP on Nasdaq
There are no Buy or Sell transactions made by ARCH Venture Partners XII, LLC since 9/12/2023
Holdings reported by ARCH Venture Partners XII, LLC for Rapport Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
3.73M |
|
|
Jun 10, 2024 |
By ARCH Venture Fund XII, L.P. |
|
|
Series A Preferred Stock |
0 |
|
|
Jun 10, 2024 |
By ARCH Venture Fund XII, L.P. |
Common Stock |
|
Series B Preferred Stock |
0 |
|
|
Jun 10, 2024 |
By ARCH Venture Fund XII, L.P. |
Common Stock |
|
Transactions reported by ARCH Venture Partners XII, LLC for Rapport Therapeutics, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.